Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 7, 2026, 01:33Riddhi Doshi: 5 Red Flags When Choosing Your IVF Doctor
-
May 7, 2026, 01:09Ting Yuan: Why IVF Fails Even When Everything Looks Perfect?
-
May 7, 2026, 00:50Elisabeth Iraola: Michelle Obama Highlights Urgency of Women’s Health Issues
-
May 6, 2026, 01:35Alison Wright: BSGE 2026 Highlights Leadership Change and Future Vision
-
May 6, 2026, 01:30Short Menstrual Cycles May Signal Early Ovarian Ageing – Fertility Plus
-
May 6, 2026, 01:27Asma Khalil: Maternal Mental Health Remains a Leading Risk
-
May 5, 2026, 16:55Pregnancy Outcomes in a Recurrent Miscarriage Population After Uterine Surgeries – Fertility and Sterility
-
May 5, 2026, 16:43MAGENTA Oocyte Scores, Morphokinetics and Live Birth – Future Fertility
-
May 5, 2026, 16:34Join Us on 16 September to Explore Challenges in Managing a Successful Fertility Service – BFS